Yamaguchi Yoshitaka, Wada Manabu, Sato Hidenori, Nagasawa Hikaru, Koyama Shingo, Takahashi Yoshimi, Kawanami Toru, Kato Takeo
Department of Neurology, Hematology, Metabolism, Endocrinology, and Diabetology, Yamagata University Faculty of Medicine, Yamagata, Japan.
Am J Hypertens. 2014 Oct;27(10):1257-67. doi: 10.1093/ajh/hpu045. Epub 2014 Mar 20.
Recent epidemiological studies reported a relationship between 24-hour ambulatory blood pressure (ABP) variability and cardiovascular events. However, the impact of ABP variability on small vessel disease (SVD) progression or cognitive decline in the elderly has seldom been investigated in community-based longitudinal studies.
Subjects (n = 210) underwent ABP monitoring, brain magnetic resonance imaging (MRI), and cognitive testing at baseline and 4 years later. ABP variability was quantified by the SD, weighted SD, coefficient of variation (CV), and average real variability (ARV). ABP variability parameters were divided into 2 groups by median values.
Multivariable logistic regression analyses showed that higher systolic CV, diastolic weighted SD, and diastolic CV were significant predictors of SVD progression (P = 0.02, 0.03, and 0.02, respectively). In subjects with SVD on the first MRI, higher systolic and diastolic ARV also predicted progression (P = 0.04 and 0.03, respectively). Higher quartiles of systolic weighted SD and CV had higher incidences of SVD progression (P trend = 0.03 and 0.03, respectively, Cochran-Armitage test), and higher quartiles of systolic ARV had higher incidences of SVD progression in subjects with SVD on the first MRI (P trend = 0.03). Higher systolic ARV was an independent predictor of cognitive decline (P < 0.01), and higher tertiles of systolic ARV had higher incidences of cognitive decline (P trend = 0.02).
This community-based longitudinal study found that increased ABP variability was associated with SVD progression, particularly in individuals with SVD at baseline. Higher systolic ARV predicted SVD progression and cognitive decline.
近期的流行病学研究报道了24小时动态血压(ABP)变异性与心血管事件之间的关系。然而,在基于社区的纵向研究中,很少有人研究ABP变异性对老年人小血管疾病(SVD)进展或认知衰退的影响。
210名受试者在基线时和4年后接受了ABP监测、脑磁共振成像(MRI)和认知测试。通过标准差(SD)、加权标准差、变异系数(CV)和平均实际变异性(ARV)对ABP变异性进行量化。ABP变异性参数按中位数分为两组。
多变量逻辑回归分析显示,较高的收缩压CV、舒张压加权SD和舒张压CV是SVD进展的显著预测因素(P分别为0.02、0.03和0.02)。在首次MRI检查时患有SVD的受试者中,较高的收缩压和舒张压ARV也可预测疾病进展(P分别为0.04和0.03)。收缩压加权SD和CV的较高四分位数SVD进展发生率较高( Cochr an-Armitage检验,P趋势分别为0.03和0.03),在首次MRI检查时患有SVD的受试者中,收缩压ARV的较高四分位数SVD进展发生率较高(P趋势=0.03)。较高的收缩压ARV是认知衰退的独立预测因素(P<0.01),收缩压ARV较高的三分位数认知衰退发生率较高(P趋势=0.02)。
这项基于社区的纵向研究发现,ABP变异性增加与SVD进展相关,尤其是基线时患有SVD的个体。较高的收缩压ARV可预测SVD进展和认知衰退。